Susceptibility test results for rifampicin among bacteriologically confirmed pulmonary tuberculosis patients. The dataset is published by the World Health Organization via the GHO platform, focusing on drug resistance monitoring. Its specific temporal and geographic coverage is not detailed in the provided metadata.
Use Cases
- Monitoring national and global trends in rifampicin-resistant TB (inferred from domain, verify after download)
- Assessing the performance of diagnostic tests for drug susceptibility (inferred from domain, verify after download)
- Informing public health policy and treatment guidelines for drug-resistant TB (inferred from domain, verify after download)
Strengths
- Published on the WHO GHO platform.
- Source organization is the World Health Organization.
Limitations
- Metadata is minimal; actual content requires verification after download.
- Column-level documentation is absent; field semantics must be inferred after download.
- Row count and temporal coverage are unknown, which may limit suitability assessment.
Provenance
- Source
- World Health Organization (WHO)
- Collection Method
- Likely aggregated from national public health surveillance systems.
- Time Range
- null
- Freshness
- Last update date is unknown; freshness unverified.
- Geography
- null